Acceleron Pharma Inc
XLRN
Get informed when a big investor buys or sells
+ FollowMarket Cap$0
Close$
$190.26
6.4% upside
Current Fair Value
6.4% upsideUndervalued by 6.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $-590,569,000.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.92 |
| Beta | 0.13 |
| Outstanding Shares | 60,937,000 |
Return
| Return on Equity | -35.49% |
|---|---|
| Return on Assets | -32.35% |
| Return on Invested Capital | -34.98% |
Valuation & Multiples
| P/E Ratio | -61.15 |
|---|---|
| PEG | -76.87 |
| Price to Sales | 178.75 |
| Price to Book Ratio | 16.25 |
| Enterprise Value to Revenue | -5.24 |
| Enterprise Value to EBIT | 2.31 |
| Enterprise Value to Net Income | 2 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Acceleron Pharma Inc
CEO: Habib Dable